Where things stand
Neural interfaces cover a spectrum from established therapies to experimental brain–computer interfaces (BCIs). Cochlear implants and deep brain stimulation for Parkinson's disease and essential tremor are long-established. Implanted BCIs that decode intention, by contrast, have mostly been tested in small early-feasibility studies with a handful of participants each.
Recent progress
- Speech. In 2023, two groups reported speech neuroprostheses for people with paralysis: a Stanford team decoded attempted speech to text at 62 words per minute (Willett et al., Nature), and a UCSF team decoded speech to text and a talking avatar (Metzger et al., Nature).
- Walking. A "digital bridge" linking a brain implant to spinal cord stimulation let a man with chronic tetraplegia walk more naturally (Lorach et al., Nature, 2023).
- Commercial entrants. Several companies, including Neuralink, Synchron and Precision Neuroscience, have implanted devices in human participants in early studies, using different approaches: high-channel-count threads, an endovascular stent electrode, and thin-film surface arrays.
What is contested
Results come from very few participants, and long-term signal stability, device longevity and day-to-day usability remain open. Company announcements often come before peer-reviewed data, so entries here distinguish published results from press releases.
What to watch
Movement from feasibility to pivotal trials, multi-year durability data, and the first regulatory approvals for communication BCIs.